Immune System Regulator Found to Protect Brain from Effects of Stroke

Immune System Regulator Found to Protect Brain from Effects of Stroke – A small molecule known to regulate white blood cells has a surprising second role in protecting brain cells from the deleterious effects of stroke, Johns Hopkins researchers report. The molecule, microRNA-223, affects how cells respond to the temporary loss…

Benefits of Early Accurate Detection Neurodegenerative Diseases

In the past decade, there has been increased information and knowledge that has enhanced physicians’ understanding of and potential management for neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease and Huntington’s disease. Research has shown that these disorders are often characterized by a presymptomatic phase, during which neuronal degeneration is likely…

Boston Scientific Defibrillators Receive CE Mark for Extended Longevity

Boston Scientific Corporation has received CE Mark approval for increased longevity projections for the INCEPTA™, ENERGEN™, PUNCTUA™, COGNIS® and TELIGEN® implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The longevity projections are based on data submitted to the European authorities and vary for each device dependent on the model…

Scientists Pair Blood Test And Gene Sequencing To Detect Cancer

Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery. “This approach uses the…

ELIQUIS (apixaban) Approved in Europe for Prevention of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

Bristol-Myers Squibb and Pfizer announced today that the European Commission has approved ELIQUIS (apixaban) for prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors. ELIQUIS is the only oral anticoagulant that has demonstrated superior risk reduction versus warfarin in the…

Surgical Infection: A brief look at Surgical Infection

Surgical Infection is an infection that occurs after surgery in the part of the body where the surgery took place. Surgical Infection is a major surgical problem in surgical practice. Most patients who have surgery do not develop an infection. However, infections develop in about 1 to 3 out of…

Wound Healing: What is Abnormal Wound Healing?

Wound healing process can be differentiated by two types which are Normal Wound Healing and Abnormal Wound Healing, Basically wound is refers to breach in normal tissue continuity resulting in a variety of cellular and molecular sequelae. Abnormal wound healing is divided into three intentions which are Wound healing by…